Literature DB >> 31085128

Vitamin D modulates human macrophage response to Mycobacterium tuberculosis DNA.

Jorge L Cervantes1, Esther Oak2, John Garcia3, Hongfei Liu4, Paolo A Lorenzini5, Deepika Batra6, Arvind Chhabra6, Juan C Salazar7, Xavier Roca4.   

Abstract

Mycobacterium tuberculosis (Mtb) is a facultative intracellular pathogen that infects macrophages where it avoids elimination by interfering with host defense mechanisms, including phago-lysosome fusion. Endosomal Toll-like receptors (TLRs) generate Type I Interferons (IFNs), which are associated with active tuberculosis (TB). We aimed to explore if DNA from different Mtb lineages lead to differences in the inflammatory response of human monocytic/macrophage cells. THP-1 cells which express two inducible reporter constructs for interferons (IFNs) as well as for NF-κB, were stimulated via endosomal delivery of Mtb DNA as a nanocomplex with PEI. DNA from different Mtb phylogenetic lineages elicited differential inflammatory responses in human macrophages. An initial relatively weak IRF-mediated response to DNA from HN878 and H37Rv increased if the cells were pre-treated with Vitamin D (Vit D) for 72 h. RNAseq of THP-1 under different transformation conditions showed that pre-treatment with Vit D upregulated several TLR9 variants, as well as genes involved in inflammatory immune response to infection, immune cell activation, Type I IFN regulation, and regulation of inflammation. Vit D appears to be important in increasing low IRF responses to DNA from certain lineages of Mtb. Variations in the IRF-mediated response to DNA derived from different Mtb genotypes are potentially important in the pathogenesis of tuberculosis since Type I IFN responses are associated with active disease. The role of Vit D in these responses could also translate into future therapeutic approaches.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mycobacterium tuberculosis; Type I IFNs; Vitamin D

Mesh:

Substances:

Year:  2019        PMID: 31085128      PMCID: PMC6626683          DOI: 10.1016/j.tube.2019.04.021

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  60 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Targeting the inflammatory response in tuberculosis.

Authors:  Jon S Friedland
Journal:  N Engl J Med       Date:  2014-10-02       Impact factor: 91.245

3.  Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.

Authors:  Cecile M Fremond; Vladimir Yeremeev; Delphine M Nicolle; Muazzam Jacobs; Valerie F Quesniaux; Bernhard Ryffel
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

4.  Differential analysis of gene regulation at transcript resolution with RNA-seq.

Authors:  Cole Trapnell; David G Hendrickson; Martin Sauvageau; Loyal Goff; John L Rinn; Lior Pachter
Journal:  Nat Biotechnol       Date:  2012-12-09       Impact factor: 54.908

5.  Vitamin D rescues impaired Mycobacterium tuberculosis-mediated tumor necrosis factor release in macrophages of HIV-seropositive individuals through an enhanced Toll-like receptor signaling pathway in vitro.

Authors:  Asha Anandaiah; Sanjeev Sinha; Medhavi Bole; Surendra K Sharma; Narendra Kumar; Kalpana Luthra; Xin Li; Xiuqin Zhou; Benjamin Nelson; Xinbing Han; Souvenir D Tachado; Naimish R Patel; Henry Koziel
Journal:  Infect Immun       Date:  2012-10-15       Impact factor: 3.441

6.  Intradermal immunization improves protective efficacy of a novel TB vaccine candidate.

Authors:  Susan L Baldwin; Sylvie Bertholet; Maria Kahn; Irina Zharkikh; Gregory C Ireton; Thomas S Vedvick; Steven G Reed; Rhea N Coler
Journal:  Vaccine       Date:  2009-03-26       Impact factor: 3.641

7.  The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.

Authors:  Susanna Commandeur; Susan J F van den Eeden; Karin Dijkman; Simon O Clark; Krista E van Meijgaarden; Louis Wilson; Kees L M C Franken; Ann Williams; Dennis Christensen; Tom H M Ottenhoff; Annemieke Geluk
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

8.  Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.

Authors:  Franck J Barrat; Thea Meeker; Josh Gregorio; Jean H Chan; Satoshi Uematsu; Shizuo Akira; Bonnie Chang; Omar Duramad; Robert L Coffman
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

9.  Mycobacterium tuberculosis subverts the TLR-2-MyD88 pathway to facilitate its translocation into the cytosol.

Authors:  Aejazur Rahman; Parveen Sobia; Neeta Gupta; Luc Van Kaer; Gobardhan Das
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Alternative splicing analysis in human monocytes and macrophages reveals MBNL1 as major regulator.

Authors:  Hongfei Liu; Paolo A Lorenzini; Fan Zhang; Shaohai Xu; Mei Su M Wong; Jie Zheng; Xavier Roca
Journal:  Nucleic Acids Res       Date:  2018-07-06       Impact factor: 16.971

View more
  2 in total

Review 1.  The Immunomodulatory Properties of Vitamin D.

Authors:  Lambros Athanassiou; Clio P Mavragani; Michael Koutsilieris
Journal:  Mediterr J Rheumatol       Date:  2022-03-31

2.  Elevated Levels of 1,25-Dihydroxyvitamin D in Plasma as a Missing Risk Factor for Celiac Disease.

Authors:  Seth Scott Bittker
Journal:  Clin Exp Gastroenterol       Date:  2020-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.